Neuland Labs - Forging Ahead
Last year we did an opening note on Neuland Labs and how the company is moving up in Pharma value chain, The company recently announced its full year revenue and the results are inline with our expectations
CMS segment outgrew other segments and now has ~28% share of total revenues up from ~26% last year, overall all segments had a good year with topline…
Keep reading with a 7-day free trial
Subscribe to Tankrich to keep reading this post and get 7 days of free access to the full post archives.